Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance

The study aims to show that treatment with LtAPD works better than a sham treatment or simply monitoring the condition closely without active treatment ("active surveillance"), in achieving complete healing of a tissue abnormality on the cervix called CIN 2, after 6 months. This will be confirmed by examining tissue samples under a microscope (histopathological examination).

Trial Details

NCT ID
NCT07730645
Phase
NA
Sponsor
University Hospital Tuebingen
Status
RECRUITING
Cancer Type
Cervical Cancer
Interventions
  • Treatment with low-thermal argon plasma devitalization
  • Sham treatment
Locations (sample)
  • Tübingen, Baden-Wurttemberg, Germany|48.52266,9.05222

Key Eligibility Criteria

  • Female sex
  • Age 18 - 40 years at the time of signing the informed consent
  • Histologically confirmed CIN 2
  • Full visibility of the entire transformation zone (Type 1 or Type 2) and entire lesion in colposcopy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Cervical Cancer Trials on Trialify →